CD274 and systemic lupus erythematosus: Finally, to monitor the dynamics of the immunoprofiling during immunosuppressant treatment, we determined the change of PD-1+ and PD-L1+ cells of four enrolled patients with SLE (clinical manifestation and regimen were in table 2) while they received immunosuppressant treatment.